News & Publications
| News: |
|---|
| new publications are now online available:
Boss K et al. (2023) Binding and detoxification efficiency of albumin decline after haemodialysis. Nephrol Dial Transplant. Klinkmann G et al. (2023) Exploring Albumin Functionality Assays: A Pilot Study on Sepsis Evaluation in Intensive Care Medicine. Int J Mol Sci. Paar M et al. (2023) Determination of binding characteristics as a measure for effective albumin using different methods. Biochim Biophys Acta Gen Subj. Agarwal B et al. (2023) Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure. J Hepatol |
| Meet us at the following events: |
|---|
| International Biotech Innovation Days 2023
Brandenburgische Technische Universität (BTU) Cottbus-Senftenberg | 17.-19 Okt 2023 |
| Current clinical trials: |
|---|
| Short titel: AFORCE-1 – Albumin FunctiOn in eaRly CancEr (DRKS00025249) Partner: MEDIACC GmbH Study center: Charité und Vivantes Berlin–Pilot study Short titel: Albumin-functionality-test in ICU patients (DRKS00025079) Partner: Fraunhofer-Instituts für Zelltherapie und Immunologie (IZI), Rostock Study center: Universitätsmedizin Rostock, Zentrum für Innere Medizin |
| News: |
|---|
| new publication of a liver dialysis device and biomarkers is now online available: Banwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba et al.; Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on chronic liver failure; Journal of Hepatology, 2023 |
| Meet us at the following events: |
|---|
| 49th ESAO-IFAO Annual Congress BERGAMO, ITALY | AUGUST 29 – SEPTEMBER 1, 2023 |
| Current clinical trials: |
|---|
| Short titel: AFORCE-1 – Albumin FunctiOn in eaRly CancEr (DRKS00025249) Partner: MEDIACC GmbH Study center: Charité und Vivantes Berlin– Pilot study Short titel: Albumin-functionality-test in ICU patients (DRKS00025079) |